Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Diabetes

Journal Scan / Research · June 27, 2019

Optimal Beta Cell–Preserving Treatment in Latent Autoimmune Diabetes in Adults

Diabetes, Obesity & Metabolism

 

Additional Info

Diabetes, Obesity & Metabolism
Investigating Optimal β-Cell-Preserving Treatment in Latent Autoimmune Diabetes in Adults: Results From a 21-Month Randomized Trial
Diabetes Obes Metab 2019 May 30;[EPub Ahead of Print], IK Hals, H Fiskvik Fleiner, N Reimers, MC Astor, K Filipsson, Z Ma, V Grill, A Björklund

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading